Neurocrine Biosciences (NBIX) Q2 2017 Earnings

9MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-0.9
-0.74
-0.59
-0.43

Details

Expected EPS
-0.73
Actual EPS
-0.9
Surprise EPS
-0.17
Surprise Percent
+23.29%

Description

Neurocrine Biosciences (NBIX) has reported earnings of -0.9 per share for Q2 2017.

0 Comments

Share your thoughts